Britzilam 25 Tablet
Marketer
Torrent Pharmaceuticals Ltd
Salt Composition
Brivaracetam (25mg)
Overview Britzilam 25 Tablet
Epileptin 25mg tablets are an anticonvulsant medication prescribed to manage epileptic seizures. This medication can be administered alone or in conjunction with other therapies. Continued use is crucial for ongoing seizure prevention. Epileptin 25mg works by reducing abnormal brain electrical activity. It can be taken with or without food, but consistent daily timing optimizes efficacy. Dosage and frequency are determined individually by your physician to effectively control seizures and may be adjusted incrementally. Long-term therapy is generally recommended. Continue taking this medication as directed by your doctor, even if feeling well; discontinuation or missed doses can exacerbate seizures. Never cease treatment without your doctor's explicit instruction, as abrupt cessation may worsen seizure activity. Common side effects include vertigo, cephalalgia, nausea, and emesis. Behavioral shifts, including aggression, irritability, and agitation, may also occur. Side effects are more prevalent initially and usually diminish with continued use. While most side effects require no medical intervention, some can be severe. Suicidal ideation has been reported in a small percentage of patients. Consult your doctor immediately if experiencing a mood deterioration. Prior to commencing treatment, inform your doctor of any hepatic or renal impairment, depressive disorders, suicidal tendencies, pregnancy, or pregnancy planning. Nursing mothers should also seek medical counsel before use.
Uses of Britzilam 25 Tablet
Convulsive disorders
Major Benefits of Britzilam 25 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Britzilam 25 Tablet whole; do not alter its form by chewing, crushing, or breaking it. This medication can be taken with or without food, although consistent timing is recommended.
Common Side effects of Britzilam 25 Tablet:
- Behavioral changes
- Agitation
- Aggressive behavior
- Dizziness
- Sedation
- Drowsiness
- Neuropsychiatric symptoms
How to use Britzilam 25 Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Britzilam 25mg tablets can be consumed with or without food; however, consistent daily timing is recommended.
How Britzilam 25 Tablet works:
Britzilam 25mg tablets are used to control seizures. The drug's mechanism involves binding to synaptic vesicle protein 2A (SV2A) receptors located on neuronal membranes. This binding action reduces excessive neuronal firing in the brain, thus inhibiting the propagation of seizure-inducing electrical impulses.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Britzilam 25 Tablet is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Using Britzilam 25 Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Britzilam 25 Tablet with breastfeeding is lacking. Seek medical advice from your physician.
DrivingUNSAFE
Taking Britzilam 25 mg tablets might reduce attentiveness, impair vision, and cause drowsiness or dizziness. Driving is inadvisable if these effects are experienced.
KidneySAFE IF PRESCRIBED
Britzilam 25 Tablet can be used safely by individuals with kidney disease; dosage modification is unnecessary. However, its use is not advised in cases of end-stage renal disease, as supporting clinical trial data is absent.
LiverCAUTION
Patients with hepatic impairment should use Britzilam 25 Tablet cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Britzilam 25 Tablet :
NA
Facts to Know About Britzilam 25 Tablet
| Label | Value |
|---|---|
| Chemical Classification | Levetiracetam Analog |
| Developing Habits | No. |
| Type of Therapy | Neuroscience |
| Behavioral Class | AED: A protein ligand within synaptic vesicle 2 |






